Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maruyama, H.
Right arrow Articles by Kawakami, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maruyama, H.
Right arrow Articles by Kawakami, H.
Related Collections
Right arrow Alzheimer's disease
Neurology 2001;57:337-339
© 2001 American Academy of Neurology


Brief Communications

Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer’s disease

H. Maruyama, MD;, Y. Izumi, MD;, M. Oda, MD;, T. Torii, MD;, H. Morino, MD;, H. Toji, MD;, K. Sasaki, MD;, H. Terasawa, MD;, S. Nakamura, MD and H. Kawakami, MD, PhD

From the Third Department of Internal Medicine (Drs. Maruyama, Izumi, Oda, Torii, Morino, Toji, Nakamura, and Kawakami), Hiroshima University School of Medicine; Kinoko Espoir Hospital (Dr. Sasaki), Kasaoka, Okayama; and Department of Neurology (Dr. Terasawa), Sumitomo Hospital, Osaka, Japan.

Address correspondence and reprint requests to Dr. Hideshi Kawakami, Third Department of Internal Medicine, Hiroshima University School of Medicine, 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551, Japan; e-mail: hkawakam{at}ipc.hiroshima-u.ac.jp

Associations between polymorphisms of the cystatin C gene (CST3) at 5' flanking region and exon 1 in Caucasian patients with late onset AD and exon 1 in a US study of late onset AD have been reported. Clinically diagnosed Japanese patients with AD and Japanese normal control subjects were assessed for the presence of polymorphisms of CST3. The authors could not confirm the previously reported association between CST3 polymorphisms and AD in Japan. Age had no effect on the CST3 genotype.




This article has been cited by other articles:


Home page
Ann. N. Y. Acad. Sci.Home page
K. BEYER, J. I. LAO, P. LATORRE, and A. ARIZA
Age at Onset: An Essential Variable for the Definition of Genetic Risk Factors for Sporadic Alzheimer's Disease
Ann. N.Y. Acad. Sci., December 1, 2005; 1057(1): 260 - 278.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. M. Cathcart, R. Huang, I. S. Lanham, E. H. Corder, and S. E. Poduslo
Cystatin C as a risk factor for Alzheimer disease
Neurology, February 22, 2005; 64(4): 755 - 757.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.